Gráfico del Precio de Acciones SCNI
SCNI Dividendos
Scinai Immunotherapeutics Ltd
$0.5
-5.06%
$-0.02
Al cierre: May 13, 16:00:00 GMT-4
$0.53
4.74%
$0.02
Mercado Posterior: May 13, 20:00:00 GMT-4
Atrás
Scinai Immunotherapeutics Ltd (SCNI) Dividendos
Estadísticas clave
Cierre Anterior
$0.533
Precio de apertura
$0.5305
Rango del día
$0.5 - $0.533
Rango de 52 semanas
$0.4548 - $6.18
Volumen
131.1K
Volumen promedio
2.3M
Rendimiento de dividendos
--
EPS (TTM)
-0.00
Cap. de mercado
$1.8M
¿Qué es SCNI?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Características
© 2026 Edgen impulsado por
